In recent years, the literature on the treatment of sleep apnea with mandibular advancement devices has expanded significantly. There are now a substantial number of Level I studies (scientifically recognized as significant, including prospective, randomized-controlled, and placebo-controlled studies) proving the effectiveness of such devices, including for long-term treatment in some cases.
Indeed, the MAD can be proposed as a first-line treatment for mild to moderate apnea/hypopnea syndrome, avoiding some surgical treatments on the soft palate and uvula that were widely used in the past but whose effectiveness is now largely questioned.
Moreover, these devices offer much better flexibility for patients (more discreet and travel-compatible, not requiring electrical power).